Managing Director & Founder
Mr. Kempe spent 18 years working for GE, the last 14 years of which was with GE Healthcare (GEHC) in a number of Strategic, Operational, and Financial leadership positions in the U.S. and Europe. He is the former Director of Strategic Alliances and VP of Home Health at GEHC, and from 2010 to 2014, drove the development of a new segment (Home Health) through the creation of a Joint Venture between GEHC and Intel Health (Care Innovations, $250 million). Additionally, he managed GEHC’s investment portfolio (20 companies, $500 million), and created the office of External Funding, securing a contract with the Qatar Foundation in 2013.
He received a Bachelor of Science from Uppsala University in Business Administration & Economics, and spent 4 years in the Swedish military.
Based on his extensive industry relationships, and strong strategic and operational expertise, Mr. Kempe will focus on deal sourcing for 37celsius, as well as business expansion and the integration of its portfolio companies.
Juan Antonio Beceiro Friedmann
Mr. Friedmann spent 22 years working in the healthcare industry, and the last 14 years with GEHC in a number of Strategic Marketing / Sales and Market Development roles in the EU. He is the former Chief Marketing Officer at GE Healthcare South Europe, where he developed strategic partnerships with large (greater than $60 million) Public-Private Partnerships, including hospital deals, Abbvie (Fit4Work program), and Medtronic (intraoperative CT & MR). Additionally, he developed and executed various go-to-market efforts for a number of products, including the introduction of innovative oncology and neuro technologies, and the deployment of the Barcelona Cardio City program.
He received a Master degree in Marketing (ESIC), Master degree in Pharmaceutical Marketing and Management (EADA) and a Bachelor’s degree in Chemical engineering (UAB).
Based on his strengths in market development and creating strategic partnerships, Mr. Friedmann will focus on strategy, alliances, and solutions for 37celsius’ portfolio companies.
Senior Transaction Advisor
Mr. Eklund has 25 years of Investment and M&A experience and extensive healthcare experience with focus on growth stage companies. Mr Eklund is the former CEO and Head of Europe at Investor Growth Capital, where he built up and managed a portfolio of over 30 transactions with 2.5B SEK invested, and subsequent exits in the Nordic region. Prior roles include Investment Director at Alfred Berg ABN AMBRO Capital, and Vice President at Handelsbanken. Mr. Eklund is actively involved on several boards in the capacity as Chairman for Moberg Pharma AB and Itrim AB, and board member of Boule Diagnostics AB, Biotage AB, Neoventa Medical AB, Memira AB, and Surgical Science. Based on his experience with growth stage companies within the healthcare sector and his extensive industry relationships, Mr Eklund will focus on actively providing advice as a member of the investment committee and in part will be focused on identifying, evaluating, and structuring new investment opportunities.
Managing Director - to be disclosed
This key team member is a seasoned deal professional with 12 years of M&A, capital markets, and strategy experience, including seven years in the healthcare industry. He has held roles of increasing responsibility in middle market M&A investment banking and growth private equity, focusing on transactions of $100 to 500 million in size across multiple industry sectors, in addition to healthcare corporate development roles focused on driving strategic acquisitions, divestitures, minority investments, partnerships, and portfolio strategy. He has completed over 20 strategic transactions totaling in excess of $2 billion in aggregate deal value.
He received a Bachelor of Arts degree from Northwestern University in Economics and Applied Mathematics, as well as a Master of Business Administration degree in Strategy and Finance from the Kellogg School of Management.
He will focus on investment execution and portfolio monitoring.
Tommy G. Thompson
Chairman and CEO of Thompson Holdings
Tommy G. Thompson is the former United States Health and Human Services (HHS) Secretary and four-term Governor of Wisconsin. Following his term in public office, he built, and continues to build with his work at Thompson Holdings, on his efforts as HHS Secretary and Governor on improving the use of information technology in hospitals, clinics, and doctors’ offices; promoting healthier lifestyles; strengthening and modernizing Medicare and Medicaid; and expanding the use of medical diplomacy around the world. From 2005 until 2009, Governor Thompson served as a senior advisor at the consulting firm Deloitte LLP and was the founding independent chairman of the Deloitte Center for Health Solutions, which researches and develops solutions to some of our nation’s most pressing health care and public health-related challenges. He currently serves on the Board of Directors of the following public companies: Physicians Realty Trust and TherapeuticsMD, Inc. (each as Chairman of the Board of Directors), Centene Corporation, C.R. Bard, Inc., Cytori Therapeutics, Inc., and United Therapeutics Corporation.
Dr. David Albert
Founder & Chief Medical Officer at AliveCor
Dr. Albert is a physician, inventor, and serial entrepreneur who has developed medical and other life-saving technologies and products over the last 30 years, turning a number of those innovations into tech startups. Today, he is a founder of three tech companies; InnovAlarm, Lifetone Technology, and AliveCor. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). Dr. Albert left GE in 2004 as Chief Scientist of GE Cardiology to disrupt several new markets. He also has authored or co-authored over 50 scientific abstracts and publications principally in the Cardiology literature, and has 37 issued U.S. patents.
President and CEO of DRA Medical Advisors
Mr. Ataide is a 30-year veteran of the healthcare industry, with deep domain expertise in a wide variety of medical devices, imaging, and healthcare I.T. markets. As the Principal of DRA Medical Advisors, Mr. Ataide provides strategic and tactical leadership to companies as they transition towards commercialization. Previously, Mr. Ataide held senior level executive positions at GE Healthcare, including President & CEO of the Patient Monitoring & Diagnostic Cardiology businesses, a global $1.3 billion division, and at Philips, as the Chief Marketing Officer of the then $6.2 billion global healthcare division. Mr. Ataide serves on a number of boards including; Ornim Medical, C8 Medisensors (previous), and chairman of the board at Intelesens. Mr. Ataide holds a Master of Science degree in Nursing Administration and Critical Care from the University of California at San Francisco, and a Bachelor of Science Degree in Nursing from San Jose State University.
President and CEO of KRM Group, LLC
Dr. Ken Melani is a seasoned executive with over 30 years of experience in the health care industry. As President and owner of KRM Group, LLC, Dr. Melani provides consultative services to health care service companies, pharmaceutical manufacturers, and private equity firms. Prior to starting KRM Group, Dr. Melani was President and CEO of Highmark Inc., where under his direction; Highmark grew to be the seventh largest insurance company in the United States with over 32 million covered lives and exceeding $15 billion in revenue. Dr. Melani’s contribution as a board member with organizations such as Telcare, Xodus Medical, Melanovus, Carmolex, MedExpress, and others has provided invaluable visionary guidance fueled by his vast experience and success in the healthcare industry. Dr. Melani has a Bachelor’s degree in Chemistry from Washington & Jefferson College, and a Doctorate of Medicine from Wake Forest University’s Bowman Gray School of Medicine.
Executive Director & Professor of Sorenson Center at U of Utah, Salt Lake City, USA
Mr. Wasden is a leading digital technology innovation consultant, professor, author, and thought leader with more than 15 years of healthcare industry experience. In addition, he has been an executive with startups and innovation acceleration. Mr. Wasden is the former Global Healthcare Leader at PWC. His prior roles include CEO of Tympany (medical device company) and CEO & Chairman SimplexityMD (medical device accelerator). He has authored over 60 articles on digital health technology and transformation.
Physician's Focus Group
qualification of target company solution and hospital relationships
Academia / Providers / Industry Innovation
strategic relationships, white papers and piloting solutions
target sharing, co-investments, portfolio synergies and network
Operational / Functional Support
compliment team’s expertise and network
Physician's Focus Group
- Dr. Ankarcrona, ICU at Danderyds Hospital & former VP of Investor Growth Capital, Stockholm, Sweden
- Dr. Lyon, Radiologist & Chief of Staff at Columbia St. Mary’s, Milwaukee, USA
- Dr. Manuel Vilches, CEO NISA Hospital of Madrid, and Managing Director of IDIS
- Dr. David Albert, Founder & Chief Medical Officer at AliveCor
Academia / Providers / Industry Innovation
- Stefan Vlachos, Karolinska University Hospital, Head of Strategic Innovation, Stockholm, Sweden
- Cameron Brackett, Vice President – Memphis Bioworks Foundation – Memphis, USA
- Andreas Hager, eHealth Lawyer and co-founder Hansen, founder of Genia, Stockholm, Sweden
- Brian O’Connor, Chair, European Connected Health Alliance, Northern Ireland
- Yuri Quintana, Ph.D. & Director Global Health Informatics, Harvard Medical School, MA, USA
Operational / Functional Support
Established network of experts and operators built over 45 years in the healthcare industry
- Talent pool of C-level executives in Med tech, Life sciences and Connected Health
- Quality, Regulatory and Compliance experts
- Healthcare Information Technology operators
- Various service providers including legal, accounting and tax